Skip to main content
Premium Trial:

Request an Annual Quote

HistoRx Lands $6M in Series B VC Cash to Help Move Its Dx Tools to Market

NEW YORK (GenomeWeb News) — HistoRx today said it has raised $6 million in a round of Series B private-equity financing.
 
The company, based in New Haven, Conn., said it will use the cash to develop and commercialize its tissue-based diagnostics products, which are based on its AQUA biomarker-analysis platform.
 
“These funds provide the resources necessary to move our product portfolio of diagnostic tests through later-stage development, FDA approval, and commercialization," HistoRx CEO Rana Gupta said in a statement.
 
The round was led by current investor Brook Venture Partners. Other backers included current investor Navigator Technology Ventures and new investors the Roche Venture Fund, Commons Capital, and Maven Capital.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.